A review of Medicaid claims in one southeastern state for children under age six in 2012 who were prescribed antipsychotic medications found 316 children with such prescriptions, and that 27% of them had multi-year exposure through 2017. The average antipsychotic exposure was 2.7 years, and 7% had near-continuous exposure over the four-year review period. The only Food and Drug Administration (FDA)-approved second-generation antipsychotic for children less than 6 years old is risperidone for the treatment of irritability associated with autism. Aripiprazole has similar indications starting at age 6. Risperidone was the most utilized antipsychotic . . .
News Report |